• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Indo US Bio-Tech standalone net profit declines 46.47% in the March 2026 quarter
Jun 01,2026
Net profit of Indo US Bio-Tech declined 46.47% to Rs 1.97 crore in the quarter ended March 2026 as against Rs 3.68 crore during the previous quarter ended March 2025. Sales declined 22.05% to Rs 26.02 crore in the quarter ended March 2026 as against Rs 33.38 crore during the previous quarter ended March 2025.

For the full year,net profit declined 19.36% to Rs 13.12 crore in the year ended March 2026 as against Rs 16.27 crore during the previous year ended March 2025. Sales rose 6.36% to Rs 110.44 crore in the year ended March 2026 as against Rs 103.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales26.0233.38 -22 110.44103.84 6
OPM %12.4113.69 -15.4018.24 -
PBDT2.654.43 -40 14.8217.63 -16
PBT2.383.87 -39 13.9216.53 -16
NP1.973.68 -46 13.1216.27 -19